Early benefit from structured care with Atorvastatin in patients with coronary heart disease and diabetes mellitus. A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.

被引：0
|
作者：
Athyros, VG
Papageorgiou, AA
Symeonidis, AN
Didangelos, TP
Pehlivanidis, AN
Bouloukos, VI
Mikhailidis, DP
机构：
[1] Aristotle Univ Thessaloniki, Atherosclerosis Unit, GR-54006 Thessaloniki, Greece
[2] Greek Soc Gen Practitioners, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Ctr Diabet, GR-54006 Thessaloniki, Greece
[4] Univ London Royal Free Hosp, London NW3 2QG, England
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
206
引用
收藏
页码：A74 / A75
页数：2
相关论文
共 50 条
  • [31] Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study
    Dale, Ane Cecilie
    Vatten, Lars
    Nilsen, Tom Ivar
    Midthjell, Kristian
    Wiseth, Rune
    BRITISH MEDICAL JOURNAL, 2008, 337 (7661): : 99 - 102
  • [32] Management of coronary artery disease in patients with and without diabetes mellitus.: Acute management reasonable but secondary prevention unacceptably poor:: A report from the Euro Heart Survey on Diabetes and the heart
    Anselmino, Matteo
    Bartnik, Malgorzata
    Malmberg, Klas
    Ryden, Lars
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 (01): : 28 - 36
  • [33] Oxidation diabetes and coronary heart disease a complex interaction: Findings from a population based study.
    Trevisan, M.
    Stranges, S.
    Browne, R.
    Dorn, J.
    Freudenheim, J.
    Hovey, K.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S109 - S109
  • [34] Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
    Raikou, M
    McGuire, A
    Colhoun, H
    Betteridge, J
    Durrington, P
    Hitman, G
    Neil, A
    Livingstone, S
    Thomason, M
    Mackness, M
    Charlton-Menys, V
    Fuller, J
    DIABETOLOGIA, 2005, 48 : A331 - A331
  • [35] Cost-effectiveness of atorvastatin (10mg) among patients with type 2 diabetes without coronary heart disease: CARDS trial analysis
    McGuire, A. J.
    Raikou, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 368 - 368
  • [36] Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The treating to new targets (TNT) study
    Shepherd, James
    Kastelein, John J. P.
    Bittner, Vera
    Deedwania, Prakash
    Breazna, Andrei
    Dobson, Stephen
    Wilson, Daniel J.
    Zuckerman, Andrea
    Wenger, Nanette K.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (06): : 1131 - 1139
  • [37] Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms
    Lauritzen, Trine
    Munkhaugen, John
    Peersen, Kari
    Kristiansen, Oscar
    Sverre, Elise
    Nebauer, Shane D.
    Villseth, Maja
    Andersen, Anders M.
    Svarstad, Anja Camilla
    Jensen, Elena Prunes
    Bergan, Stein
    Husebye, Einar
    Vethe, Nils Tore
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (04) : 887 - 895
  • [38] Intensive lipid lowering with atorvastatin provides early and sustained benefit in patients with stable coronary disease: A secondary analysis of the treating to new targets (TNT) study
    LaRosa, John C.
    Grundy, Scott
    Waters, David D.
    CIRCULATION, 2006, 114 (18) : 796 - 796
  • [39] Glucose lowering treatment is prognostically important in patients with coronary artery disease and newly detected, diabetes mellitus. A report from a Euro heart survey
    Anselmino, Matteo
    Ohrvik, John
    Malmberg, Klas
    Ryden, Lars
    CIRCULATION, 2007, 116 (16) : 849 - 849
  • [40] Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: The design of the TEAMcare study
    Katon, Wayne
    Lin, Elizabeth H. B.
    Von Korff, Michael
    Ciechanowski, Paul
    Ludman, Evette
    Young, Bessie
    Rutter, Carolyn
    Oliver, Malia
    McGregor, Mary
    CONTEMPORARY CLINICAL TRIALS, 2010, 31 (04) : 312 - 322
12345